Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients

Lignende værker

• Efficacy of Fulvestrant in Heavily Pretreated Postmenopausal Women with Advanced Breast Cancer: A Preliminary Report
  af: Yoo, Changhoon, et al.
  Udgivet: (2011)
• Eribulin Efficacy on Brain Metastases in Heavily Pretreated Patients with Metastatic Breast Cancer
  af: Sabatier, Renaud, et al.
  Udgivet: (2021)
• A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and nonsteroidal (anastrozole) aromatase inhibitors on biomarkers in postmenopausal women with hormone receptor-positive locally advanced breast cancer
  af: Freedman, OC, et al.
  Udgivet: (2009)
• Phase II Studies of Gemcitabine and Cisplatin in Heavily and Minimally Pretreated Metastatic Breast Cancer
  af: Chew, Helen K., et al.
  Udgivet: (2009)
• Fulvestrant in treatment for metastatic breast cancer
  af: L. Yu. Vladimirova, et al.
  Udgivet: (2019-12-01)